Sensitization of A-549 lung cancer cells to Cisplatin by Quinacrine-loaded lipidic nanoparticles via suppressing Nrf2 mediated defense mechanism
Autor: | Mohammadbagher Pirouzpanah, Mehdi Sabzichi, Mostafa Mohammadi, Shiva Mahmoudi, Marjan Ghorbani, Hossain Bijanpour, Jamal Mohammadian, Mohsen Rashidi, Fatemeh Ramezani, Shahram Ahmadian, Nazila Fathi Maroufi |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Programmed cell death Cell Survival NF-E2-Related Factor 2 Antineoplastic Agents Cellular defense response Pharmacology 03 medical and health sciences 0302 clinical medicine medicine Humans Cisplatin A549 cell Liposome Dose-Response Relationship Drug Chemistry Cancer Drug Synergism General Medicine respiratory system medicine.disease 030104 developmental biology A549 Cells Quinacrine 030220 oncology & carcinogenesis Liposomes Cancer cell Drug delivery Nanoparticles medicine.drug |
Zdroj: | Naunyn-Schmiedeberg's Archives of Pharmacology. 394:1521-1528 |
ISSN: | 1432-1912 0028-1298 |
DOI: | 10.1007/s00210-021-02079-1 |
Popis: | Nuclear factor erythroid 2-related factor 2 (Nrf2) is believed to be responsible for the control mechanisms of cellular defense response and master regulator of antioxidant system by adjustment of endogenous antioxidants, phase II detoxifying enzymes and transporters, so inhibition of Nrf2 could be considered molecule target to overcome drug resistance and cancer progression. By harnessing liposome as an advanced nanoparticles transporter, we formulated Quinacrine known as nrf2 inhibitor into nano-carrier, and sensitized A-549 lung tumor cells to Cisplatin. The aim of this work was to prepare liposome nano-carriers to enhance the bioavailability of Quinacrine and to improve passive targeting in A549 cells. Quinacrine formulation into liposome exposed a mean particle size of 80±5 nm in passive targeting and 110±3 after decoration with chitosan oligosaccharides (COS), respectively. The highest amount of cell death (p |
Databáze: | OpenAIRE |
Externí odkaz: |